Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
PAVULON (pancuronium bromide) is a non-depolarizing neuromuscular blocking agent administered via injection used during anesthesia to facilitate intubation and surgical paralysis. It works by competitively blocking acetylcholine at the neuromuscular junction, preventing muscle contraction. This injectable is a foundational anesthetic adjunct with decades of clinical use.
Mature injectable with LOE approaching; commercial teams are likely consolidating or transitioning focus to next-generation agents, signaling smaller team size and reduced investment.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
PAVULON offers minimal career growth opportunity as a mature, LOE-approaching injectable with zero linked job postings. Employment on this product typically involves defensive operations, regulatory maintenance, and supply chain management rather than brand-building or innovation roles.
Worked on PAVULON at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.